Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Unilateral vs Bilateral Hippocampal Avoidance in WBRT for Brain Metastases

A phase 2 trial compares unilateral and bilateral hippocampal avoidance during whole-brain radiotherapy with memantine for brain metastases.

Blood abstract examines the genomic and clinical landscape of RAS mutations in AML, a pathway central to proliferation,…

A phase 2/3 bladder cancer trial is evaluating izalontamab brengitecan, an EGFR x HER3 agent designed to target…

A narrative review examines when inferior vena cava filters may help in cancer-associated thrombosis and why evidence remains…

Nature Communications study examines molecular heterogeneity in prostate cancer and the clinical relevance of genomic driver alterations across…

DailyMed’s updated ifosfamide label reinforces boxed warnings, dosing with mesna and hydration, and key toxicities in testicular cancer…

LUCID pairs stimulated Raman imaging with explainable AI to improve noninvasive bladder cancer detection from urine cells.

AbelZeta’s phase 2 Prizlon-cel study will test dual CD19/CD20 CAR T therapy in relapsed large B-cell lymphoma after…

University of Oklahoma Health Sciences Center is recruiting open-rank oncology faculty with cancer research expertise and startup support…

AI-enabled lung nodule triage increased referrals and procedures across three US clinics, with more early cancers identified but…

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds